Dashboard

ImmuCell Corp. (ICCC)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

CEO

Michael F. Brigham

Employees

54

Industry

-

Sector

-

Headquarters

Portland

Exchange

NASDAQ

Summary Stats

Market Cap

39.6M

Revenue

20.1M

Net Income

-529K

EPS

$0.11

Price-to-Earnings

45.1

Price-to-Book

1.24

Debt-to-Equity

0.45

News

Analyst Ratings

Price targets projected by 0 analysts

High

$0.00

Average

$0.00

Low

$0.00

Ratings calculated by 0 analysts

Buy

0

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q4 2022

Last Earnings

Not Available

Actual

-$0.21 -

Consensus

-

Report Date

Year Ago

0.01

Year Ago Change %

Down 2200%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites